Indoco Remedies gets tentative USFDA approval for Canagliflozin Tablets
Canagliflozin improves glycemic control in adults with type 2 diabetes mellitus
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Zydus gets final USFDA nod for Methylene Blue Injection
Methylene Blue Injection is an oxidation-reduction agent indicated for the treatment of pediatric and adult patients with acquired…
Venus Remedies gets marketing approvals from Philippines, Saudi Arabia for three drugs
While Saudi Arabia is the largest pharma market in GCC region, Philippines happens to be the second largest market in South East…
AstraZeneca shares data from HIMALAYA, MATTERHORN Phase III studies at ESMO Asia Congress 2023
The International Agency for Research on Cancer (IARC) forecasts a 58 per cent surge in GI cancer cases by 2040 globally
Sentynl completes asset transfer of CUTX-101 Copper Histidinate product candidate for treatment of…
A rolling submission of the CUTX-101 New Drug Application (NDA) to the FDA is ongoing, with expected completion in 2024
Lupin gets US FDA approval for Varenicline Tablets
They are indicated for use as an aid to smoking cessation treatment
Vibcare Healthcare opens pharma manufacturing facility in Panchkula, Haryana
Built with an investment of Rs 40 crores, the facility spans over five acres
Akums’ acquires new formulation facility in Baddi
It is slated to become operational in the year 2024
Takeda signs MoU with BIRAC to support healthcare start-ups
Besides supporting healthcare startups, the partnership will also contribute to India’s aspiration of emerging as a $300 billion…
Lex Witness to host 9th Annual Pharma Legal & Compliance Summit 2023 in Mumbai
The summit is scheduled for December 8, 2023 at the Courtyard by Marriott, Mumbai, Andheri East